Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment.
Aghayan HR, Salimian F, Abedini A, Fattah Ghazi S, Yunesian M, Alavi-Moghadam S, Makarem J, Majidzadeh-A K, Hatamkhani A, Moghri M, Danesh A, Haddad-Marandi MR, Sanati H, Abbasvandi F, Arjmand B, Azimi P, Ghavamzadeh A, Sarrami-Forooshani R.
Aghayan HR, et al. Among authors: azimi p.
Stem Cell Res Ther. 2022 Jul 28;13(1):365. doi: 10.1186/s13287-022-02953-6.
Stem Cell Res Ther. 2022.
PMID: 35902979
Free PMC article.
Clinical Trial.